TMDX today
$91.38-$0.62 (-0.67%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourBearish
15 minBearish
5 minBullish
Daily trend turns up above $120.91
Key levels
Resistance$108.55
Resistance$101.70
Support$90.67
Support$84.05
Latest news & SEC filings
SEC FilingTransMedics Group, Inc. filed an insider trading report (Form 4)
AnalystUBS keeps Neutral rating on TransMedics Group, lifts price target to $88
AnalystUBS lifts TransMedics Group target to $88 from $77, Neutral kept
AnalystNeedham keeps Buy rating on TransMedics Group, lifts target to $110
All TMDX news →About TransMedics
TransMedics is a medical technology company that develops organ perfusion systems for transplant therapy. Its Organ Care System (OCS) is a portable platform that keeps donor hearts, lungs, and livers functioning outside the body. The company also offers a national service for organ procurement, perfusion, and logistics, including air and ground transportation. It serves transplant centers and patients in the United States and Europe.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
TransMedics Group, Inc. (TMDX)
What Is the Price Target for TMDX?
SEPT Low Target
$80.00
SEPT Mid Target
$118.00
SEPT High Target
$120.00
Analyst Consensus
$118.00
Is TMDX a Buy or Sell Right Now?
Thesis
- •Revenue growing 37.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TMDX.
Start Free Trial →Is TMDX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$90.70
64
Moat Score
NARROW
7/9
Piotroski Score
4.9
Altman Z-Score
What Is Smart Money Doing with TMDX?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TOBIN JAMES R | director | Sale | 59 | $6K | Nov 9, 2026 |
| TOBIN JAMES R | director | Sale | 4,000 | $380K | Nov 9, 2026 |
| Araujo Fernando N. | officer | Buy | 22,969 | - | Oct 28, 2026 |
| Lovell Stephanie | director | Buy | 2,922 | - | May 20, 2026 |
| Weill David | director | Buy | 2,922 | - | May 20, 2026 |
| RAINES MERILEE | director | Buy | 2,922 | - | May 20, 2026 |
| Gunderson Thomas J. | director | Buy | 2,922 | - | May 20, 2026 |
| Basile Edward M | director | Buy | 2,922 | - | May 20, 2026 |
| TOBIN JAMES R | director | Buy | 2,922 | - | May 20, 2026 |
| Kania Edwin | director | Buy | 2,922 | - | May 20, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TMDX Growth Story
Revenue YoY
37.1%
3yr Revenue CAGR
86.4%
EPS Growth YoY
382.18%
FCF Growth YoY
265.0%
Revenue Trend
STRONG
Dark Pool Trades for TMDX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TMDX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:17 | $91.38 | 7,600 | $$694K | BUY |
| 21:00:00 | $91.38 | 1,024 | $$94K | SELL |
| 19:41:56 | $92.94 | 2,295 | $$213K | SELL |
| 19:33:07 | $93.10 | 1,100 | $$102K | BUY |
| 18:44:35 | $92.50 | 1,200 | $$111K | MIDPOINT |
5 dark pool trades shown · $$1.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TMDX
PREVIEWSEPT Investing provides real-time options flow tracking for TMDX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $90 | Dec 4 | 21 | $$2550 | 5 | SWEEP |
| CALL | $90 | Dec 4 | 21 | $$5100 | 10 | SWEEP |
| CALL | $90 | Dec 4 | 21 | $$1020 | 2 | SWEEP |
| CALL | $90 | Dec 4 | 21 | $$1530 | 3 | SWEEP |
| CALL | $90 | Dec 4 | 21 | $$510 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for TransMedics Group, Inc. (TMDX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TMDX — frequently asked questions
What is TMDX stock price today?
TransMedics Group, Inc. (TMDX) is at $91.38, down 0.67% (-$0.62) at the Nov 13, 2026 close.
Why is TMDX stock moving today?
Latest TMDX news — Nov 12, 2026: TransMedics Group, Inc. filed an insider trading report (Form 4) · Nov 9, 2026: UBS keeps Neutral rating on TransMedics Group, lifts price target to $88
What is the TMDX price target?
The average analyst price target for TMDX is $118.00, ranging from $80 to $120, based on 9 analysts.
What do analysts rate TMDX?
Analyst ratings for TMDX: 0 Buy, 19 Hold, 0 Sell — consensus Hold.
Did TMDX beat earnings?
TMDX last reported on Nov 5, 2026: EPS $0.51 vs $0.30 expected — a beat of 71.4%.
What is TMDX's P/E ratio?
TMDX trades at a P/E of 25.1 vs a Healthcare average of 17.7.
Does TMDX pay a dividend?
TMDX does not currently pay a dividend.
What are TMDX support and resistance levels?
Support: $90.67, $84.05, $76.00. Resistance: $101.70, $108.55, $119.14.
What are insiders doing with TMDX?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on TMDX?
Nov 12, 2026: TransMedics Group, Inc. filed an insider trading report (Form 4) · Nov 9, 2026: UBS keeps Neutral rating on TransMedics Group, lifts price target to $88 · Nov 9, 2026: UBS lifts TransMedics Group target to $88 from $77, Neutral kept